Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the <scp>GO ASIA</scp> initiative

Abstract

More severe liver disease can be suspected or ruled out based on factors identified in this study. Utilisation of structured lifestyle program, vitamin E and pioglitazone was limited despite this being a cohort of biopsy-proven NAFLD patients with majority of patients having NASH.